Phenotypic and Genotypic Characterization of Antimicrobial-Resistant (AMR) Strains from the ATCC® Collection
IMARI 2026
Las Vegas, Nevada, United States
January 29, 2026Abstract
Antimicrobial resistance (AMR) is a global health crisis recognized by the WHO Priority Pathogens List, which identifies critical threats such as carbapenem-resistant Acinetobacter baumannii and Candida auris. Trichophyton indotineae is an emerging fungal pathogen that has recently been isolated in the US. These pathogens pose significant challenges for treatment and infection control. To accelerate the development of diagnostics and therapeutics, researchers need access to standardized, well-characterized strains. ATCC addresses this need by providing a curated collection of bacterial and fungal AMR strains, each extensively characterized both phenotypically and genotypically. Strains include minimum inhibitory concentration (MIC) values, susceptibility profiles, and whole-genome sequencing (WGS) data generated using Illumina and Oxford Nanopore platforms for high accuracy and depth. Annotated genomes and methylation data are available through the ATCC Genome Portal (genomes.atcc.org). By bridging genomic insights with clinical applications, ATCC empowers global efforts to combat AMR and supports innovation in antifungal and antibacterial research.
Download the poster to explore the phenotypic and genotypic characterization of AMR strains in the ATCC collection.
DownloadPresenter
Shahin Ali, PhD
Senior Scientist, Collections, ATCC
Dr. Ali is a Senior Scientist at ATCC with over 13 years of experience in the field of fungal biology and plant-pathogen interactions. Before joining ATCC, Dr. Ali worked for the USDA-ARS at Beltsville Agricultural Research Center, Maryland. He obtained his PhD from University College Dublin, Ireland.
Explore our featured resources
Drug-resistant Bacteria
ATCC offers authenticated antimicrobial-resistant bacterial strains that provide essential tools for the development of novel therapeutics and detection methods.
More
Drug-resistant Fungi
ATCC provides authenticated fungal strains for the development, verification, and evaluation of novel antifungal drugs.
More
Drug-resistant Protozoa
ATCC provides strains of drug-resistant protozoa to scientists who are developing novel therapies and diagnostic assays to eradicate drug-resistant pathogens that cause diseases such as malaria and African sleeping sickness.
More